Basic Information
RNALocate ID: RLID-D:11000135
RNA Symbol: hsa-miR-335-5p
Localization: Exosome
RNA Information
RNA Name: hsa-miR-335-5p
RNA ID: miRBase:MIMAT0000765
RNA Category: miRNA
Species: Homo sapiens
Sequence:
Localization Information
Tissue/Cell Line: Blood|Breast milk|Endothelial cells|Seminal fluid
Database: EVmiRNA
Other Subcellular Localization
RNALocate ID Localization Tissue/Cell line PubMed ID
RLID:01002092 Nucleus Neural progenitor cells 21363885
RLID:11002662 Exosome Serum 18589210
RLID:11002663 Exosome Saliva 19627513
RLID:11002664 Exosome B cell line (Raji)|Jurkat-derived T cell line (J77cl20)|Primary dendritic cells 21505438
RLID:11002665 Exosome Renal cancer cells 21670082
RLID:11002666 Exosome Breast milk 22211110
RLID:11002667 Exosome Brain tissue 23382797
RLID:11002668 Exosome Plasma 23663360
RLID:11002669 Exosome Serum 25349172
RLID:11002670 Microvesicle Seminal plasma 23539611
RLID-D:11000442 Microvesicle Colon cancer cell line (LIM1863)|Fibroblasts|Mesenchymal stem cells
ncRNA Disease Information
Resource RNA Symbol Disease Link
MNDR hsa-miR-335-5p Splenic marginal zone lymphoma MNDR-E-MI-40952
MNDR hsa-miR-335-5p Multiple sclerosis chronic progressive MNDR-E-MI-40953
MNDR hsa-miR-335-5p Medulloblastoma MNDR-E-MI-40954
MNDR hsa-miR-335-5p Ovarian clear cell carcinoma MNDR-E-MI-40955
MNDR hsa-miR-335-5p Uterine corpus endometrial carcinoma MNDR-E-MI-40956
MNDR hsa-miR-335-5p Lymphoma non-hodgkin MNDR-E-MI-40957
MNDR hsa-miR-335-5p Estrogen-receptor positive breast cancer MNDR-E-MI-40958
MNDR hsa-miR-335-5p Estrogen-receptor negative breast cancer MNDR-E-MI-40959
MNDR hsa-miR-335-5p Progesterone-receptor positive breast cancer MNDR-E-MI-40960
MNDR hsa-miR-335-5p Progesterone-receptor negative breast cancer MNDR-E-MI-40961
MNDR hsa-miR-335-5p Her2-receptor positive breast cancer MNDR-E-MI-40962
MNDR hsa-miR-335-5p Breast cancer luminal MNDR-E-MI-40963
MNDR hsa-miR-335-5p Precursor cell lymphoblastic leukemia-lymphoma MNDR-E-MI-40964
MNDR hsa-miR-335-5p Dermatomyositis MNDR-E-MI-40965
MNDR hsa-miR-335-5p Prostate cancer MNDR-E-MI-40966
MNDR hsa-miR-335-5p Gastric cancer MNDR-E-MI-40967
MNDR hsa-mir-335-5p Gastric cancer MNDR-E-MI-40968
MNDR hsa-miR-335-5p Alzheimer disease MNDR-E-MI-40969
MNDR hsa-miR-335-5p Bladder cancer MNDR-E-MI-40970
MNDR hsa-miR-335-5p Sarcoma MNDR-E-MI-40971
MNDR hsa-miR-335-5p Dysautonomia familial MNDR-E-MI-40972
MNDR hsa-miR-335-5p Myotonic dystrophy MNDR-E-MI-40973
MNDR hsa-miR-335-5p Duchenne muscular dystrophy MNDR-E-MI-40974
MNDR hsa-miR-335-5p Facioscapulohumeral muscular dystrophy MNDR-E-MI-40975
MNDR hsa-miR-335-5p Leukemia MNDR-E-MI-40976
MNDR hsa-miR-335-5p Huntington disease MNDR-E-MI-40977
MNDR hsa-miR-335-5p Cardiovascular disease MNDR-E-MI-40978
MNDR hsa-miR-335-5p Uterine fibroid MNDR-E-MI-40979
MNDR hsa-miR-335-5p Lung cancer MNDR-E-MI-40980
MNDR hsa-miR-335-5p Parkinson disease MNDR-E-MI-40981
MNDR hsa-miR-335-5p Basal-like breast cancer MNDR-E-MI-40982
MNDR hsa-miR-335-5p Thyroid cancer MNDR-E-MI-40983
MNDR hsa-miR-335-5p Pituitary neoplasms MNDR-E-MI-40984
MNDR hsa-miR-335-5p Pancreatic cancer MNDR-E-MI-40985
MNDR hsa-miR-335-5p Rectum adenocarcinoma MNDR-E-MI-40986
MNDR hsa-miR-335-5p Nephroblastoma MNDR-E-MI-40987
MNDR hsa-miR-335-5p Colon cancer MNDR-E-MI-40988
MNDR hsa-miR-335-5p Colon adenocarcinoma MNDR-E-MI-40989
MNDR hsa-miR-335-5p Multiple sclerosis relapsing-remitting MNDR-E-MI-40990
MNDR hsa-miR-335-5p Familial ovarian cancer MNDR-E-MI-40991
MNDR hsa-miR-335-5p Prostate adenocarcinoma MNDR-E-MI-40992
MNDR hsa-miR-335-5p Carcinoma ductal breast MNDR-E-MI-40993
MNDR hsa-miR-335-5p Invasive ductal carcinoma MNDR-E-MI-40994
MNDR hsa-miR-335-5p Glioblastoma MNDR-E-MI-40995
MNDR hsa-miR-335-5p Malignant astrocytoma MNDR-E-MI-40996
MNDR hsa-miR-335-5p Glioma MNDR-E-MI-40997
MNDR hsa-miR-335-5p Chronic obstructive pulmonary disease MNDR-E-MI-40998
MNDR hsa-miR-335-5p Nemaline myopathy MNDR-E-MI-40999
MNDR hsa-miR-335-5p Neurilemmoma MNDR-E-MI-41000
MNDR hsa-miR-335-5p Amyotrophic lateral sclerosis MNDR-E-MI-41001
MNDR hsa-miR-335-5p Temporal lobe epilepsy MNDR-E-MI-41002
MNDR hsa-miR-335-5p Osteosarcoma MNDR-E-MI-41003
MNDR hsa-miR-335-5p Liposarcoma MNDR-E-MI-41004
MNDR hsa-miR-335-5p Breast carcinoma MNDR-E-MI-41005
MNDR hsa-miR-335-5p Meningioma MNDR-E-MI-41006
MNDR hsa-miR-335-5p Pituitary adenoma MNDR-E-MI-41007
MNDR hsa-miR-335-5p Lung squamous cell carcinoma MNDR-E-MI-41008
MNDR hsa-miR-335-5p Lung adenocarcinoma MNDR-E-MI-41009
MNDR hsa-miR-335-5p Thyroid carcinoma MNDR-E-MI-41010
MNDR hsa-miR-335-5p Pancreatic adenocarcinoma MNDR-E-MI-41011
MNDR hsa-miR-335-5p Carcinoma renal cell MNDR-E-MI-41012
MNDR hsa-miR-335-5p Papillary renal cell carcinoma MNDR-E-MI-41013
MNDR hsa-miR-335-5p Clear cell renal cell carcinoma MNDR-E-MI-41014
MNDR hsa-miR-335-5p Chromophobe renal cell carcinoma MNDR-E-MI-41015
MNDR hsa-miR-335-5p Cholangiocarcinoma MNDR-E-MI-41016
MNDR hsa-miR-335-5p Esophageal cancer MNDR-E-MI-41017
MNDR hsa-miR-335-5p HIV MNDR-E-MI-41018
MNDR hsa-miR-335-5p Oncocytoma MNDR-E-MI-41019
MNDR hsa-miR-335-5p Lung small cell carcinoma MNDR-E-MI-41020
MNDR hsa-miR-335-5p Head and neck squamous cell carcinoma MNDR-E-MI-41021
MNDR hsa-miR-335-5p Testicular germ cell cancer MNDR-E-MI-41022
MNDR hsa-miR-335-5p T acute lymphoblastic leukemia MNDR-E-MI-41023
MNDR hsa-miR-335-5p Acute t cell leukemia MNDR-E-MI-41024
MNDR hsa-miR-335-5p Fibromyalgia MNDR-E-MI-41025
MNDR hsa-miR-335-5p Breast invasive carcinoma MNDR-E-MI-41026
MNDR hsa-miR-335-5p Hepatocellular carcinoma MNDR-E-MI-41027
MNDR hsa-miR-335-5p Familiar ovarian carcinoma MNDR-E-MI-41028
MNDR hsa-miR-335-5p B-cell lymphoma MNDR-E-MI-41029
MNDR hsa-miR-335-5p Rheumatoid arthritis MNDR-E-MI-41030
MNDR hsa-miR-335-5p T-cell leukemia MNDR-E-MI-41031
MNDR hsa-miR-335-5p Neuroblastoma MNDR-E-MI-41032
MNDR hsa-miR-335-5p Barrett's adenocarcinoma MNDR-E-MI-41033
MNDR hsa-miR-335-5p Hodgkin lymphoma MNDR-E-MI-41034
MNDR hsa-miR-335-5p Burkitt lymphoma MNDR-E-MI-41035
MNDR hsa-miR-335-5p Myeloid leukemia MNDR-E-MI-41036
MNDR hsa-miR-335-5p Neuromyelitis optica MNDR-E-MI-41037
MNDR hsa-miR-335-5p Acute myeloid leukemia MNDR-E-MI-41038
MNDR hsa-miR-335-5p Colorectal cancer MNDR-E-MI-41039
MNDR hsa-miR-335-5p Nasopharynx carcinoma MNDR-E-MI-41040
MNDR hsa-miR-335-5p Ependymoma MNDR-E-MI-41041
MNDR hsa-miR-335-5p Nasopharyngeal cancer MNDR-E-MI-41042
MNDR hsa-miR-335-5p Cerebral hemorrhage traumatic MNDR-E-MI-41043
MNDR hsa-miR-335-5p Intracranial hemorrhage hypertensive MNDR-E-MI-41044
MNDR hsa-miR-335-5p Sarcopenia MNDR-E-MI-41045
MNDR hsa-miR-335-5p Stroke lacunar MNDR-E-MI-41046
MNDR hsa-miR-335-5p Non-alcoholic fatty liver disease MNDR-E-MI-41047
MNDR hsa-miR-335-5p Barrett's carcinogenesis MNDR-E-MI-41048
MNDR hsa-miR-335-5p Breast cancer her3+ negative MNDR-E-MI-41049
MNDR hsa-miR-335-5p Solid-pseudopapillary neoplasm of pancreas MNDR-E-MI-41050
RNA Interaction Information
Resource RNA Symbol Species Link RNALocate ID
RNAInter ARPC5L Homo sapiens RR00130405
TOP